15-day lockdown must to break deadly chain of transmission
By IANS |
5 Views
New Delhi, April 14 : As India witnesses an unprecedented surge in Covid caseloads, voices for a short-duration national lockdown or in severely-hit states/UTs grew louder on Wednesday and experts urged the Centre to immediately plan and execute a 15-day lockdown to break the chain of infection and manage the second wave of the pandemic.
The fact is that when India went into a 21-day national lockdown in March last year, the total number of active Covid cases was a mere over 500. The lockdown then failed to stop the surge as the first wave happened after that period and devastated businesses and normal life.
New Delhi: As India witnesses an unprecedented surge in Covid caseloads, voices for a short-duration national lockdown or in severely-hit states/UTs grew
India News: NEW DELHI: As India witnesses an unprecedented surge in Covid caseloads, voices for a short-duration national lockdown or in severely-hit states/UTs g.
Amaravati Lockdown Model
Experts also cited the example of Amaravati lockdown model for breaking the deadly chain of transmission.
Amaravati in Maharashtra s Vidarbha region saw a rapid surge in February. Following this the state government imposed a week-end lockdown on February 18 to break the chain of virus transmission. But this effort failed as cases were still going north.
It was followed by a stricter lockdown for seven days, from February 22 to March 1, and was extended for another one week from March 1 to March 8.
The lockdown successfully broke the chain of transmission and active caseload decreased.
According to Neha Gupta, Infectious Diseases Specialist at Medanta - The Medicity, Gurgaon, strict social distancing norms are very important at this juncture, which will help in stabilising the overburdened healthcare services as hospitals are facing bed crunch and shortage of anti-viral drugs.
All you need to know about the Sputnik V Covid jab
By IANS |
5 Views
RDIF sets target of 50m doses a month for Sputnik in India.. Image Source: IANS News
New Delhi, April 13 : As Hyderabad-based pharmaceutical major Dr. Reddy s Laboratories (DRL) announces it has received permission from the Drugs Controller General of India (DCGI) to import Sputnik V vaccine in India for restricted use in emergencies, here are a few things that you need to know about the Covid-19 jab.
After Covishield and Covaxin, Sputnik V, developed by Gamaleya National Research Institute of Epidemiology and Microbiology in Moscow, is now the third Covid-19 vaccine to get emergency use approval in India.